Scientists at UCLA's David Geffen School of Medicine are working with bioluminescent, fluorescent, and positron emission tomography (PET) technologies to reduce infections in post-surgical orthopedic patients as well as fight against metabolic cancer.
Amid increased complexity of regulations, PerkinElmer's QSight™ Pesticide Analyzer solution provides labs with more uptime and competitive advantage to meet regulatory requirements.
A review of the growing dangers associated with antibiotics in milk and PerkinElmer's latest technology to discover these drugs in milk samples.
Missouri University Science and Technology researchers develop new SP-ICP-MS methodology to test for the presence of nanomaterials in drinking water.
Researchers offer evidence of the importance of epithelial-to-mesenchymal transition (EMT) in the progression of chronic kidney disease.
PerkinElmer recently introduced the Avio™ 200 instrument as the world's smallest inductively coupled plasma optical emission spectrometer (ICP-OES).
With dangerous levels of arsenic found in apple juice, PerkinElmer offers a new fast and reliable HPLC/ICP-MS process to measure arsenic in juice.
In a medical first, UNC researchers engineer and record skin cells becoming cancer killers using PerkinElmer’s IVIS system.
Monash Institute of Pharmaceutical Sciences is working to develop an inhaled oxytocin treatment for PPH, excessive bleeding after childbirth that kills an estimated 140,000 women a year.
Groundbreaking research using PerkinElmer's Vectra multispectral imaging platform may lead to new immunotherapy treatments for cancer.